A call to action for more focus on the management of the type 2 diabetes epidemic around the globe.

Updated guideline recommendations regarding the monitoring and management of patients’ blood pressure levels to reduce the risk of cardiovascular events.

Considerations that factor into decisions for reducing LDL levels in patients with diabetes with statin therapy or options, such as PCSK9 inhibitors and ezetimibe.

How to best prevent and manage statin-associated myalgias when managing cholesterol levels in patients with type 2 diabetes at risk for cardiovascular events.

Guidance on the use of aspirin therapy in patients at risk of cardiovascular events, based on recently updated guideline recommendations.

Takeaways of the most recent ADA guidelines in terms of treating patients with diabetes with metformin, SGLT2 inhibitors, and GLP-1 receptor agonists.

The benefits of using new therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, to treat type 2 diabetes.

A discussion on using continuous glucose monitoring systems to improve the management of type 2 diabetes.

Recommendations to address accessibility and coverage issues that affect the use of continuous glucose monitoring into widespread clinical practice.

A description of hybrid artificial insulin pump systems for type 2 diabetes and a discussion highlighting potential integration with continuous glucose monitoring systems.

Guidance in terms of counseling women on pregnancy, gestational diabetes, and the risk for cardiovascular events.

Limitations managing type 2 diabetes with new technologies used as monitoring tools that need to be addressed moving forward.